M S Kaminski - JoVE Visualize

Showing results (11-20 of 41) with videos related to

Pageof 5

Sort By:

Hybridoma|January 1, 1985

Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitroD G Maloney, M S Kaminski, D Burowski, et al.

Science (New York, N.Y.)|June 30, 1989

Production of mammastatin, a tissue-specific growth inhibitor, by normal human mammary cellsP R Ervin, M S Kaminski, R L Cody, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1986

Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variantsM S Kaminski, K Kitamura, D G Maloney, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1986

Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphomaT Y Basham, M S Kaminski, K Kitamura, et al.

Biochemical and Biophysical Research Communications|December 31, 1991

Hsp27 is a mediator of sustained smooth muscle contraction in response to bombesinK N Bitar, M S Kaminski, N Hailat, et al.

Journal of the American Optometric Association|December 1, 1993

Free radicals and antioxidant supplementation: a review of their roles in age-related macular degenerationA M van der Hagen, D P Yolton, M S Kaminski, et al.

Cancer|December 24, 1997

Preliminary results from intensity-based CT-SPECT fusion in I-131 anti-B1 monoclonal-antibody therapy of lymphomaK F Koral, S Lin, J A Fessler, et al.

Annals of Internal Medicine|June 1, 1986

Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapyM S Kaminski, C N Coleman, T V Colby, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998

Nonmyeloablative iodine-131 anti-B1 radioimmunotherapy as outpatient therapyV L Gates, J E Carey, J A Siegel, et al.

Clinical Immunology (Orlando, Fla.)|June 21, 2001

Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigensT Nordøy, A Kolstad, M K Tuck, et al.

Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:

Pageof 5

Hybridoma|January 1, 1985

Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitroD G Maloney, M S Kaminski, D Burowski, et al.

Science (New York, N.Y.)|June 30, 1989

Production of mammastatin, a tissue-specific growth inhibitor, by normal human mammary cellsP R Ervin, M S Kaminski, R L Cody, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1986

Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variantsM S Kaminski, K Kitamura, D G Maloney, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1986

Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphomaT Y Basham, M S Kaminski, K Kitamura, et al.

Biochemical and Biophysical Research Communications|December 31, 1991

Hsp27 is a mediator of sustained smooth muscle contraction in response to bombesinK N Bitar, M S Kaminski, N Hailat, et al.

Journal of the American Optometric Association|December 1, 1993

Free radicals and antioxidant supplementation: a review of their roles in age-related macular degenerationA M van der Hagen, D P Yolton, M S Kaminski, et al.

Cancer|December 24, 1997

Preliminary results from intensity-based CT-SPECT fusion in I-131 anti-B1 monoclonal-antibody therapy of lymphomaK F Koral, S Lin, J A Fessler, et al.

Annals of Internal Medicine|June 1, 1986

Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapyM S Kaminski, C N Coleman, T V Colby, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998

Nonmyeloablative iodine-131 anti-B1 radioimmunotherapy as outpatient therapyV L Gates, J E Carey, J A Siegel, et al.

Clinical Immunology (Orlando, Fla.)|June 21, 2001

Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigensT Nordøy, A Kolstad, M K Tuck, et al.

Pageof 5